Leaflet BIXEBRA 7.5mg film-coated tablets


Indicated for: angina pectoris; heart failure

Substance: ivabradine (antihypertensive)

ATC: C01EB17 (Cardiovascular system | Other cardiac preparations)

Ivabradine is a medication used to treat stable angina (chest pain caused by reduced blood flow to the heart) and chronic heart failure. It works by reducing the heart rate without affecting the strength of heart contractions, which helps decrease the heart's oxygen demand and improve cardiac function.

It is particularly indicated for patients who cannot tolerate beta-blockers or those who require additional treatment to control heart rate. Ivabradine is effective in reducing angina symptoms and lowering the risk of hospitalization due to heart failure.

Side effects may include visual disturbances (perception of bright lights), bradycardia (slowed heart rate), dizziness, fatigue, or headaches. It is important for the medication to be taken as prescribed by a doctor, and patients should be monitored to avoid complications.

General data about BIXEBRA 7.5mg

  • Substance: ivabradine
  • Date of last drug list: 01-05-2026
  • Commercial code: W62963004
  • Concentration: 7.5mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 56
  • Product type: generic
  • Price: 81.37 RON
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Holder: KRKA, D.D., NOVO MESTO - SLOVENIA
  • Number: 9204/2016/04
  • Shelf life: 2 years

Concentrations available for ivabradine

  • 5mg
  • 7.5mg

Combinations with other substances

Compensation lists for BIXEBRA 7.5mg KRKA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

81.37 RON

40.63 RON

40.74 RON